KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to -$33.3 million.

  • Charles River Laboratories International's Gains from Investment Securities rose 67.55% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.7 million, marking a year-over-year decrease of 8210.56%. This contributed to the annual value of -$33.3 million for FY2024, which is 1549.48% down from last year.
  • As of FY2024, Charles River Laboratories International's Gains from Investment Securities stood at -$33.3 million, which was down 1,549.48% from $2.3 million recorded in FY2023.
  • Charles River Laboratories International's Gains from Investment Securities' 5-year high stood at $60.1 million during FY2020, with a 5-year trough of -$34.3 million in FY2021.
  • Its 3-year average for Gains from Investment Securities is -$15.7 million, with a median of -$16.1 million in 2022.
  • As far as peak fluctuations go, Charles River Laboratories International's Gains from Investment Securities spiked by 114.23% in 2023, and later tumbled by 1,549.48% in 2024.
  • Charles River Laboratories International's Gains from Investment Securities (Yearly) stood at $60.1 million in 2020, then slumped by 157.12% to -$34.3 million in 2021, then surged by 53.01% to -$16.1 million in 2022, then skyrocketed by 114.23% to $2.3 million in 2023, then crashed by 1,549.48% to -$33.3 million in 2024.